RNS Number : 8124B
Samsung Electronics Co. Ld
02 October 2025
 

Report on Share Repurchase Results

 

1. Details of repurchase (unit: KRW, share)

- Share repurchase period: July 9, 2025-September 29, 2025

 * The report submission date : July 8, 2025

 * The above period is based on contract date.

- Common shares (Registered common shares)

Order quantity: 49,726,000 shares / Acquired quantity: 49,720,620 shares

Acquisition price per share: KRW 70,594 / Total acquisition amount: KRW mil. 3,509,995

- Other shares (Registered preferred shares)

Order quantity: 6,967,000 shares / Acquired quantity: 6,966,473 shares

Acquisition price per share: KRW 57,692 / Total acquisition amount: KRW mil. 401,913

 

2. Consistency between planned and actual acquisition

- Planned amount : Common shares: KRW mil. 3,509,995 / Other shares: KRW mil. 401,913

- Acquired amount : Common shares: 3,509,995 / Other shares: 401,913

 

3. Holding status of treasury shares after acquisition (as of October 2, 2025)

Quantity

Ratio

Amount(KRW mil)

Common shares

91,833,777

1.55%

5,896,112

Other shares

13,603,461

1.67%

713,933

Total

105,437,238

1.57%

6,610,045

* The above amounts are book values including related fees.

 

4. Changes in share holdings by major shareholders before and after acquisition (as of September 29, 2025)

Share Type

Report date of acquisition

End date of acquisition

Reason for change

Samsung Life

Insurance

Common

503,904,843

503,904,843

-

Other

43,950

43,950

-

Samsung Life

Insurance

(special account)

Common

5,131,418

4,802,512

on-market transactions

Other

210,156

301,683

on-market transactions

Total

Common

509,036,261

508,707,355

-

Other

254,106

345,633

-

Sub total

509,290,367

509,052,988

-

* The above period is based on contract date.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFSWSWEEISEIS